Compiling comments that experts make about stocks while on public TV.
Top Picks
Daily Opinions
Follow us
Sign up for daily alerts!There is 1 registered member and 147 guests viewing this site
Compiling comments that experts make about stocks while on public TV.
Top Picks
Daily Opinions
Follow us
Sign up for daily alerts!There is 1 registered member and 147 guests viewing this site
2012-11-19
| Signal | Price | Bias | Subject | Owned |
|---|---|---|---|---|
| TOP PICK | $62.920 | BULLISH | NORTH AMERICAN - LARGE | Yes |
12 drugs under patent after a current one comes off patent. A hepatitis drug is about to come out as well. It could hit its 52 week high.
Mohsin Bashir
Associate Portfolio Manager,
Highwater Capital Management http://www.highwatercapital.com/
Opinions: Recent | Top Picks | My Portfolio |
This site is used by investors to track what stock experts say. It is useful as an online investing tool for due diligence, and for getting a feel for how companies are thought of by investment experts. This site should not be your only resource or reference, but it should be one of the investing tools in your arsenal for wise investing in the stock market. Stockchase only reports on what has been discussed by individuals who appear on business television programs, in particular Business News Network . Stockchase, in its reporting, neither recommends nor promotes any investment strategies that have been discussed. On the VERY rare occasion we make a mistake. If you see something that you know is not right, feel free to email us. at Mistake was made! If there is a problem with the site, feel free to email us. at StockChase Site Problems |
